Novel SMP Responds Directly to Enzymatic Activity
By HospiMedica International staff writers Posted on 14 Mar 2019 |

Image: A shape memory polymer (SMP) that responds to enzymes could promote healing (Photo courtesy of Syracuse University).
A new study shows how a novel shape memory polymer (SMP) that responds to exposure to enzymes could soon be used to treat open wounds, infections, and cancer.
Developed by researchers at Syracuse University (NY, USA) and Bucknell University (Lewisburg, PA, USA), the new SMP includes a shape fixing component, poly(ε-caprolactone) (PCL), that is vulnerable to enzymatic degradation, and a shape memory component, Pellethane, that is enzymatically stable. As the shape fixing PCL component undergoes enzymatically-catalyzed degradation, the SMP can return to its original, programmed shape. It requires no additional trigger, such as a change in temperature, and could thus respond to cellular activity.
The researchers also analyzed material properties, shape memory performance, and cytocompatibility of the enzymatically-catalyzed shape memory response. The results demonstrate enzymatic recovery, as contraction of tensile specimens, and that shape recovery is achieved by degradation of the PCL shape-fixing phase. In addition, both the materials composing the SMP and the process of enzymatic shape recovery were cytocompatible. The study describing the SMP was published on January 15, 2019, in Acta Biomaterialia.
“We anticipate that the materials we're developing could have broad application in health care. For example, our SMPs could be used in drugs that only activate when the target cells or organ are in the desired physiological state, in scaffolds that guide tissue regeneration in response to the behavior of the regenerating tissue itself, and in decision-making biosensors that guide patient treatment more effectively,” said senior author Professor James Henderson, PhD, of Syracuse University. “We're very excited to have achieved these first enzymatically responsive SMPs.”
“The enzymatic sensitivity of the material allows it to respond directly to cell behavior. For instance, you could place it over a wound, and as the tissue remodeled and degraded it, the SMP would slowly pull the wound closed,” said lead author candidate Shelby Buffington, MSc, a biomedical engineering PhD candidate at Syracuse University. “It could be adapted to play a role in treating infections and cancer by adjusting the material's chemistry.”
SMPs include foams, scaffolds, meshes, and other polymeric substrates that have the ability to return from a deformed state (temporary shape) to their original (permanent) shape induced by an external stimulus, such as a temperature change, an electric or magnetic field, light, or a chemical solution. As well as polymers in general, SMPs also cover a wide property-range from stable to biodegradable, from soft to hard, and from elastic to rigid, depending on the structural units that constitute the SMP.
Related Links:
Syracuse University
Bucknell University
Developed by researchers at Syracuse University (NY, USA) and Bucknell University (Lewisburg, PA, USA), the new SMP includes a shape fixing component, poly(ε-caprolactone) (PCL), that is vulnerable to enzymatic degradation, and a shape memory component, Pellethane, that is enzymatically stable. As the shape fixing PCL component undergoes enzymatically-catalyzed degradation, the SMP can return to its original, programmed shape. It requires no additional trigger, such as a change in temperature, and could thus respond to cellular activity.
The researchers also analyzed material properties, shape memory performance, and cytocompatibility of the enzymatically-catalyzed shape memory response. The results demonstrate enzymatic recovery, as contraction of tensile specimens, and that shape recovery is achieved by degradation of the PCL shape-fixing phase. In addition, both the materials composing the SMP and the process of enzymatic shape recovery were cytocompatible. The study describing the SMP was published on January 15, 2019, in Acta Biomaterialia.
“We anticipate that the materials we're developing could have broad application in health care. For example, our SMPs could be used in drugs that only activate when the target cells or organ are in the desired physiological state, in scaffolds that guide tissue regeneration in response to the behavior of the regenerating tissue itself, and in decision-making biosensors that guide patient treatment more effectively,” said senior author Professor James Henderson, PhD, of Syracuse University. “We're very excited to have achieved these first enzymatically responsive SMPs.”
“The enzymatic sensitivity of the material allows it to respond directly to cell behavior. For instance, you could place it over a wound, and as the tissue remodeled and degraded it, the SMP would slowly pull the wound closed,” said lead author candidate Shelby Buffington, MSc, a biomedical engineering PhD candidate at Syracuse University. “It could be adapted to play a role in treating infections and cancer by adjusting the material's chemistry.”
SMPs include foams, scaffolds, meshes, and other polymeric substrates that have the ability to return from a deformed state (temporary shape) to their original (permanent) shape induced by an external stimulus, such as a temperature change, an electric or magnetic field, light, or a chemical solution. As well as polymers in general, SMPs also cover a wide property-range from stable to biodegradable, from soft to hard, and from elastic to rigid, depending on the structural units that constitute the SMP.
Related Links:
Syracuse University
Bucknell University
Latest Critical Care News
- New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
- Battery-Powered Wearable Device Monitors Joint Pain
- Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws
- Breakthrough Sensor Technology Tracks Stroke After Effects
- New Study Demonstrates AI-Assisted Detection of Reduced Ejection Fraction
- Novel 3D Adipose Tissue Bioprinting Method to Find Applications in Regenerative Medicine
- Miniaturized Pacemaker for Newborns Found Safe and Effective for Up to Two Years
- World’s First 3D Neural Electrode Uses Soft Actuation Technology to Avoid Nerve Damage
- Smartwatch Algorithm Detects Cardiac Arrest
- Blood-Brain Barrier “Organ Chip” Treats Brain Tumors Unreachable by Chemotherapy
- AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline
- World-First Technology Uses Real-Time ECG Signal Analysis for Accurate CVAD Placement
- AI Outperforms Humans at Analyzing Long-Term ECG Recordings
- Smart Sensor Enables Precise, Self-Powered Tracking of Healing Wounds
- Skin Patch Activates New Gene Switch to Treat Diabetes
- Zinc-Based Dissolvable Implants to Transform Bone Repair
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more